We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Reinstates Internal Investigation Rule to Protect Whistleblowers
FDA Reinstates Internal Investigation Rule to Protect Whistleblowers
July 12, 2013
The FDA has reinstated a final rule on internal investigations involving FDA staff, saying it is needed to protect whistleblowers and prevent the subversion of investigations into research misconduct.